Influence of hormone replacement therapy on the outcome of iliac angioplasty and stenting

Journal of Vascular Surgery

Volumn 33, Issue 2 SUPPL., 2001, Pages 85-92

  Timaran, Carlos H ^a   Stevens, Scott L ^a   Grandas, Oscar H ^a   Freeman, Michael B ^a   Goldman, Mitchell H ^a  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; AGED; ANGIOPLASTY; ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; CORONARY STENT; DIABETES MELLITUS; FEMALE; GRAFT PATENCY; HORMONE SUBSTITUTION; HUMAN; ILIAC ARTERY; LIMB SALVAGE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; THROMBOEMBOLISM; TREATMENT INDICATION;

EID: 0035108718     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2001.111667     Document Type: Article

References (29)

1. Iliac arteries: Reanalysis of results of balloon angioplasty
2. Aortoiliac stent deployment versus surgical reconstruction: Analysis of outcome and cost
3. Influence of anatomic distribution of atherosclerosis on the outcome of revascularization with iliac stent placement
4. Self-expandable stents for the treatment of iliac artery obstructive lesions: Long-term success and prognostic factors
5. Hormone therapy to prevent disease and prolong life in postmenopausal women
6. The protective effects of estrogen on the cardiovascular system
7. Postmenopausal hormone therapy and mortality
8. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group
9. Intravascular stents
10. Recommended standards for reports dealing with lower extremity ischemia: Revised version
11. Reporting standards for lower extremity arterial endovascular procedures. Society for Vascular Surgery/International Society for Cardiovascular Surgery
12. Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. A statement for health professionals from a special writing group of the Councils on Cardiovascular Radiology, Arteriosclerosis, CardioThoracic and Vascular Surgery, Clinical Cardiology, and Epidemiology and Prevention, the American Heart Association
13. Percutaneous transluminal angioplasty and primary stenting of the iliac arteries in 288 patients
14. Percutaneous transluminal angioplasty and stenting for iliac artery occlusive disease
15. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease
16. Non-parametric estimation from incomplete observations
17. Regression models and life tables
18. Multivariate survival analysis using Cox's regression model
19. Normal aortoiliac diameters by CT
20. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators
21. Effects on haemostasis of hormone replacement therapy with transdermal estradiol and oral sequential medroxyprogesterone acetate: A 1-year, double-blind, placebo-controlled study
22. Risk of venous thromboembolism in users of hormone replacement therapy
23. Prospective study of exogenous hormones and risk of pulmonary embolism in women
24. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens
25. Influence of hormone replacement therapy on graft patency after femoropopliteal by pass
26. Stent grafts in occlusive arterial disease
27. Surgical transluminal iliac angioplasty with selective stenting: Long term results assessed by means of duplex scanning
28. Randomized comparison of primary stent placement versus angioplasty with selective stent placement in patients with iliac artery obstructive disease